Biotech | February 01, 2022
Moderna’s Covid-19 `Spikevax’ vaccine gets full USFDA approval
Spikevax has received approval by regulators in more than 70 countries, including Canada, Japan, the European Union, the UK, Israel
Spikevax has received approval by regulators in more than 70 countries, including Canada, Japan, the European Union, the UK, Israel
Clarithromycin tablets USP, 250 mg and 500 mg have an estimated market size of US $ 11 million for twelve months ending September 2021 according to IQVIA
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
Companies plan to commercialize breath-based detection of lung infection and transplant rejection
First participants enrolled in clinical trial received Omicron-based vaccine candidate as a two-dose primary series and as a booster dose
The country is sixth among the most affected countries by active cases
This agreement allows Natco to expand access to Covid-19 medicines in 105 countries in generic name
Yoga helps to build a strong immune system and daily breathing regime of 10-minute helps in the long run
Krivida Novus can detect the Omicron variant and its sub-lineages in 45 minutes
Prof Karikó's research was most notably used by Pfizer/BioNTech and Moderna to build COVID-19 mRNA vaccines
Subscribe To Our Newsletter & Stay Updated
